(Q42718669)

English

Impact of CYP2C9*3, VKORC1-1639, CYP4F2rs2108622 genetic polymorphism and clinical factors on warfarin maintenance dose in Han-Chinese patients

scientific article published on July 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Impact of CYP2C9*3, VKORC1-1639, CYP4F2rs2108622 genetic polymorphism and clinical factors on warfarin maintenance dose in Han-Chinese patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

1 reference

based on heuristic

inferred from title

author name string

Ruijuan Liang

1

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Lei Li

2

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Cuilan Li

3

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Yuanfeng Gao

4

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Wenling Liu

5

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Dayi Hu

6

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Yihong Sun

7

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

publication date

1 July 2012

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Journal of Thrombosis and Thrombolysis

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

34

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

120-125

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

https://scigraph.springernature.com/pub.10.1007/s11239-012-0725-7

0 references

The oral anticoagulant saga: past, present, and future

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0725-7

21 January 2018

Pharmacogenetics of warfarin: current status and future challenges

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0725-7

21 January 2018

Association of Vitamin K epoxide reductase complex 1 (VKORC1) variants with warfarin dose in a Hong Kong Chinese patient population

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0725-7

21 January 2018

Genotypes of the cytochrome p450 isoform, CYP2C9, and the vitamin K epoxide reductase complex subunit 1 conjointly determine stable warfarin dose: a prospective study.

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0725-7

21 January 2018

VKORC1 gene variations are the major contributors of variation in warfarin dose in Japanese patients.

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0725-7

21 January 2018

Allelic variants in the CYP2C9 and VKORC1 loci and interindividual variability in the anticoagulant dose effect of warfarin in Italians.

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0725-7

21 January 2018

Use of pharmacogenetic and clinical factors to predict the therapeutic dose of warfarin

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0725-7

21 January 2018

Common VKORC1 and GGCX polymorphisms associated with warfarin dose

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0725-7

21 January 2018

Association of warfarin dose with genes involved in its action and metabolism

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0725-7

21 January 2018

The largest prospective warfarin-treated cohort supports genetic forecasting

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0725-7

21 January 2018

Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0725-7

21 January 2018

Influence of CYP2C9 and VKORC1 on warfarin dose, anticoagulation attainment and maintenance among European-Americans and African-Americans

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0725-7

21 January 2018

Different contributions of polymorphisms in VKORC1 and CYP2C9 to intra- and inter-population differences in maintenance dose of warfarin in Japanese, Caucasians and African-Americans

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0725-7

21 January 2018

Factors influencing warfarin dose requirements in African-Americans

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0725-7

21 January 2018

Influence of coagulation factor, vitamin K epoxide reductase complex subunit 1, and cytochrome P450 2C9 gene polymorphisms on warfarin dose requirements.

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0725-7

21 January 2018

CYP4F2 genetic variant alters required warfarin dose

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0725-7

21 January 2018

Association of VKORC1 and CYP2C9 polymorphisms with warfarin dose requirements in Japanese patients

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0725-7

21 January 2018

Warfarin pharmacogenetics: CYP2C9 and VKORC1 genotypes predict different sensitivity and resistance frequencies in the Ashkenazi and Sephardi Jewish populations.

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0725-7

21 January 2018

Influence of CYP4F2 rs2108622 (V433M) on warfarin dose requirement in Asian patients

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0725-7

21 January 2018

CYP4F2 is a vitamin K1 oxidase: An explanation for altered warfarin dose in carriers of the V433M variant

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0725-7

21 January 2018

CYP4F2 rs2108622: a minor significant genetic factor of warfarin dose in Han Chinese patients with mechanical heart valve replacement

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0725-7

21 January 2018

A general method for isolation of high molecular weight DNA from eukaryotes

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0725-7

21 January 2018

Contribution of age, body weight, and CYP2C9 and VKORC1 genotype to the anticoagulant response to warfarin: proposal for a new dosing regimen in Chinese patients

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0725-7

21 January 2018

Randomized trial of genotype-guided versus standard warfarin dosing in patients initiating oral anticoagulation

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0725-7

21 January 2018

Genetic and clinical predictors of warfarin dose requirements in African Americans

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0725-7

21 January 2018

Impact of CYP4F2 rs2108622 on the stable warfarin dose in an admixed patient cohort.

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0725-7

21 January 2018

Genetic determinants of warfarin dosing in the Han-Chinese population

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0725-7

21 January 2018

VKORC1, CYP2C9 and CYP4F2 genetic-based algorithm for warfarin dosing: an Italian retrospective study.

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0725-7

21 January 2018

Genetic factors (VKORC1, CYP2C9, EPHX1, and CYP4F2) are predictor variables for warfarin response in very elderly, frail inpatients

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0725-7

21 January 2018

Genetic factors contribute to patient-specific warfarin dose for Han Chinese

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0725-7

21 January 2018

Estimation of the warfarin dose with clinical and pharmacogenetic data

1 reference

https://pubmed.ncbi.nlm.nih.gov/22528326

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Warfarin Response and Vitamin K Epoxide Reductase Complex 1 in African Americans and Caucasians

1 reference

https://pubmed.ncbi.nlm.nih.gov/22528326

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Factors affecting the interindividual variability of warfarin dose requirement in adult Korean patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/22528326

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Estimation of warfarin maintenance dose based on VKORC1 (-1639 G>A) and CYP2C9 genotypes

1 reference

https://pubmed.ncbi.nlm.nih.gov/22528326

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The International HapMap Project

1 reference

https://pubmed.ncbi.nlm.nih.gov/22528326

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11239-012-0725-7

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42718669&oldid=1967116654"